To address the nationwide concern of costly immunotherapy agents, this article features health system inpatient and outpatient strategies that can help mitigate their costs.
Carina Verdier Dolan, PharmD, BCOP
Advertisement
Articles by Carina Verdier Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
- Evolving Practices in Managing Costly Immunotherapy
Published: February 8th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
3
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
